Rapid detection and identification of overdose drugs in saliva by surface-enhanced Raman scattering using fused gold colloids
- PMID: 24310588
- PMCID: PMC3857074
- DOI: 10.3390/pharmaceutics3030425
Rapid detection and identification of overdose drugs in saliva by surface-enhanced Raman scattering using fused gold colloids
Abstract
The number of drug-related emergency room visits in the United States doubled from 2004 to 2009 to 4.6 million. Consequently there is a critical need to rapidly identify the offending drug(s), so that the appropriate medical care can be administered. In an effort to meet this need we have been investigating the ability of surface-enhanced Raman spectroscopy (SERS) to detect and identify numerous drugs in saliva at ng/mL concentrations within 10 minutes. Identification is provided by matching measured spectra to a SERS library comprised of over 150 different drugs, each of which possess a unique spectrum. Trace detection is provided by fused gold colloids trapped within a porous glass matrix that generate SERS. Speed is provided by a syringe-driven sample system that uses a solid-phase extraction capillary combined with a SERS-active capillary in series. Spectral collection is provided by a portable Raman analyzer. Here we describe successful measurement of representative illicit, prescribed, and over-the-counter drugs by SERS, and 50 ng/mL cocaine in saliva as part of a focused study.
Figures









References
-
- The DAWN Report. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; Rockville, MD, USA: Dec 28, 2010. Highlights of the 2009 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Available online http://dawninfo.samhsa.gov (accessed on 26 April 2011)
-
- Rainey P.M., Schonfeld D.J. Toxicology, Monitoring of Drug Therapy, and Testing for Substance Abuse. In: Zaret B.L., Jatlow P.I., Katz L.D., editors. The Yale University School of Medicine Patient's Guide to Medical Tests. Houghton-Mifflin Co; New York, NY, USA: 1997. pp. 587–596.
-
- Burgess S. U.S. Food and Drug Administration; Silver Spring, MD, USA: Jan 13, 2011. FDA limits acetaminophen in prescription combination products; requires liver toxicity warnings. Available online http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm239894.htm (accessed on 26 April 2011)
-
- Bates D.W., Soldin S.J., Rainey P.M., Miceli J.N. Strategies for Physician Education and Therapeutic Drug Monitoring. Clin. Chem. 1998;44:401–407. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous